Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleAN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.AuthorsKim, W.S.; Assouline, S.; Bartlett, N.L.; Bosch, F.; Budde, L.E.; Cheah, C.; Gregory, G.P.; Hong, J.; Ku, M.; Marlton, P.; Matasar, M.; Nastoupil, L.; Panizo, C.; Sehn, L.H.; Tzachanis, D.; Chu, W.; Hernandez, M.G.; Kwan, A.; Li, C.C.; Sison, I.SubjectsTHERAPEUTICS; MANTLE cell lymphomaPublicationHematological Oncology, 2019, Vol 37, p567ISSN0278-0232Publication typeArticleDOI10.1002/hon.15_2632